[Comparative evaluation of the new antiserotonin preparations, sandomigran and lizenil, in treating patients suffering from migraine].
D000328:Adult; D002560:Cerebrovascular Circulation / Q000187:drug effects; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003604:Czechoslovakia; D004341:Drug Evaluation; D004873:Ergolines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy*; D010918:Pizotyline / Q000627:therapeutic use*; D012702:Serotonin Antagonists; D013548:Sweden; D013876:Thiophenes / Q000627:therapeutic use*; D014508:Urea / Q000031:analogs & derivatives / Q000627:therapeutic use
D004873:Ergolines; D012702:Serotonin Antagonists; D013876:Thiophenes; D010918:Pizotyline; D014508:Urea
Sravnitel'naia otsenka novykh antiserotoninovykh preparatov sandomigrana i lizenila pri lechenii bol'nykh, stradaiushchikh migren'iu